Skip to main content
. Author manuscript; available in PMC: 2005 Sep 29.
Published in final edited form as: J Clin Endocrinol Metab. 2005 Mar 1;90(5):2768–2774. doi: 10.1210/jc.2004-2521

Fig. 2.

Fig. 2

Ganirelix dose-response study illustrated in a 34-yr-old man. Each set of LH concentrations includes a 2-h baseline (0–120 min), 16 h of monitoring after saline or ganirelix injection (open arrow, at 130 min), and 3 additional hours of sampling after fixed iv GnRH bolus (bold arrow, at 1080 min). Data reflect 10-min sampling beginning at 1800 h.